1. Abildgaard, U., 1979, A review of antithrombin III, in: The Physiological Inhibitors of Coagulation and Fibrinolysis (D. Collen, B. Wilman, and M. Verstroete, eds.), Elsevier/North-Holland, pp. 19–29, Amsterdam.
2. Abildgaard, U., 1981, Antithrombin and related inhibitors of coagulation, in: Recent Advances in Blood Coagulation (L. Poller, ed.), pp. 151–173, Churchill Livingstone, Edinburgh.
3. Akhmeteli, M. A., Aledort, L. M., Alexaniants, S., Bulanov, A. G., Elston, R. C, Ginter, E. K., Goussev, A., Graham, J. B., Hermans, J., Larrieu, M. J., Lothe, F., McLaren, A. D., Manucci, P. M., Prentice, C. R. M., and Veltkamp, J. J., 1977, Methods for the detection of haemophilia carriers: A memorandum, Bull. WHO 55:675–702.
4. Aoki, N., 1981, Genetic abnormalities of the fibrinolytic system, in: Hemophilia and Haemostasis (D. Menache, D. M. Surgenor, and H. Anderson, eds.), pp. 229–247, Alan R. Liss, New York.
5. Aoki, N., Moroi, M., Sakata, Y., Yoshida, N., and Matsuda, M., 1978, Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis, J. Clin. Invest. 61:1186–1195.